These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

986 related articles for article (PubMed ID: 19656558)

  • 1. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
    Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
    BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
    Broekhuijsen K; van Baaren GJ; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp KW; Scheepers HC; Bremer HA; Rijnders RJ; van Loon AJ; Perquin DA; Sporken JM; Papatsonis DN; van Huizen ME; Vredevoogd CB; Brons JT; Kaplan M; van Kaam AH; Groen H; Porath MM; van den Berg PP; Mol BW; Franssen MT; Langenveld J;
    Lancet; 2015 Jun; 385(9986):2492-501. PubMed ID: 25817374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.
    Koopmans CM; Bijlenga D; Aarnoudse JG; van Beek E; Bekedam DJ; van den Berg PP; Burggraaff JM; Birnie E; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; le Cessie S; van Loon AJ; Mol BW; van der Post JA; Roumen FJ; Scheepers HC; Spaanderman ME; Stigter RH; Willekes C; van Pampus MG
    BMC Pregnancy Childbirth; 2007 Jul; 7():14. PubMed ID: 17662114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trial.
    Tajik P; van der Tuuk K; Koopmans CM; Groen H; van Pampus MG; van der Berg PP; van der Post JA; van Loon AJ; de Groot CJ; Kwee A; Huisjes AJ; van Beek E; Papatsonis DN; Bloemenkamp KW; van Unnik GA; Porath M; Rijnders RJ; Stigter RH; de Boer K; Scheepers HC; Zwinderman AH; Bossuyt PM; Mol BW
    BJOG; 2012 Aug; 119(9):1123-30. PubMed ID: 22703475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.
    Mundle S; Bracken H; Khedikar V; Mulik J; Faragher B; Easterling T; Leigh S; Granby P; Haycox A; Turner MA; Alfirevic Z; Winikoff B; Weeks AD
    Lancet; 2017 Aug; 390(10095):669-680. PubMed ID: 28668289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planned delivery or expectant management for late preterm pre-eclampsia in low-income and middle-income countries (CRADLE-4): a multicentre, open-label, randomised controlled trial.
    Beardmore-Gray A; Vousden N; Seed PT; Vwalika B; Chinkoyo S; Sichone V; Kawimbe AB; Charantimath U; Katageri G; Bellad MB; Lokare L; Donimath K; Bidri S; Goudar S; Sandall J; Chappell LC; Shennan AH;
    Lancet; 2023 Jul; 402(10399):386-396. PubMed ID: 37393919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.
    de Sonnaville CMW; Hukkelhoven CW; Vlemmix F; Groen H; Schutte JM; Mol BW; van Pampus MG
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):58-67. PubMed ID: 31486156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Chappell LC; Brocklehurst P; Green ME; Hunter R; Hardy P; Juszczak E; Linsell L; Chiocchia V; Greenland M; Placzek A; Townend J; Marlow N; Sandall J; Shennan A;
    Lancet; 2019 Sep; 394(10204):1181-1190. PubMed ID: 31472930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial.
    Tajik P; van Wyk L; Boers KE; le Cessie S; Zafarmand MH; Roumen F; van der Post JA; Porath M; van Pampus MG; Spaanderdam ME; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; van Lith JM; Bossuyt PM; Mol BW; Scherjon SA;
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():20-5. PubMed ID: 24192662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.
    Bernardes TP; Zwertbroek EF; Broekhuijsen K; Koopmans C; Boers K; Owens M; Thornton J; van Pampus MG; Scherjon SA; Wallace K; Langenveld J; van den Berg PP; Franssen MTM; Mol BWJ; Groen H
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):443-453. PubMed ID: 30697855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Adverse Maternal Outcomes between Early- and Late-Onset Superimposed Preeclampsia.
    Onishi K; Seagraves E; Baraki D; Donaldson T; Barake C; Abuhamad A; Huang JC; Kawakita T
    Am J Perinatol; 2024 May; 41(S 01):e2010-e2016. PubMed ID: 37207676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
    van Baaren GJ; Broekhuijsen K; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp K; Scheepers H; Bremer HA; Rijnders R; van Loon AJ; Perquin D; Sporken J; Papatsonis D; van Huizen ME; Vredevoogd CB; Brons J; Kaplan M; van Kaam AH; Groen H; Porath M; van den Berg PP; Mol B; Franssen M; Langenveld J;
    BJOG; 2017 Feb; 124(3):453-461. PubMed ID: 26969198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
    Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
    BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
    Bernardes TP; Broekhuijsen K; Koopmans CM; Boers KE; van Wyk L; Tajik P; van Pampus MG; Scherjon SA; Mol BW; Franssen MT; van den Berg PP; Groen H
    BJOG; 2016 Aug; 123(9):1501-8. PubMed ID: 27173131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
    Zwertbroek EF; Franssen MTM; Broekhuijsen K; Langenveld J; Bremer H; Ganzevoort W; van Loon AJ; van Pampus MG; Rijnders RJP; Sikkema MJ; Scherjon SA; Woiski MD; Mol BWJ; van Baar AL; Groen H;
    Am J Obstet Gynecol; 2019 Aug; 221(2):154.e1-154.e11. PubMed ID: 30940558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the HYPITAT trial on doctors' behaviour and prevalence of eclampsia in the Netherlands.
    van der Tuuk K; Koopmans CM; Groen H; Mol BW; van Pampus MG;
    BJOG; 2011 Dec; 118(13):1658-60. PubMed ID: 21985398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies?
    Hermes W; Koopmans CM; van Pampus MG; Franx A; Bloemenkamp KW; van der Post J; Porath M; Tamsma JT; Mol BW; de Groot CJ
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):30-4. PubMed ID: 24011382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of induction of labour versus expectant management in women with impending post-term pregnancies: the 41 week - 42 week dilemma.
    Kortekaas JC; Bruinsma A; Keulen JK; van Dillen J; Oudijk MA; Zwart JJ; Bakker JJ; de Bont D; Nieuwenhuijze M; Offerhaus PM; van Kaam AH; Vandenbussche F; Mol BW; de Miranda E
    BMC Pregnancy Childbirth; 2014 Oct; 14():350. PubMed ID: 25338555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
    Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
    BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.